Black Diamond Therapeutics (BDTX) Profit After Tax (2018 - 2026)
Black Diamond Therapeutics (BDTX) posted Profit After Tax of -$9.2 million for Q1 2026, up 39.32% on a QoQ basis from -$15.1 million in Q4 2025, and down 116.22% year-over-year from $56.5 million in Q1 2025.
Black Diamond Therapeutics (BDTX) Profit After Tax (2018 - 2026) Analysis & Trends
Black Diamond Therapeutics' Profit After Tax history runs 9 years deep, the most recent figure standing at -$9.2 million for Q1 2026.
- Quarterly Profit After Tax fell 116.22% year-over-year to -$9.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$43.2 million (down 939.77% YoY) and the FY2025 annual result came in at $22.4 million, up 132.12% from the prior year.
- Profit After Tax was -$9.2 million for Q1 2026 at Black Diamond Therapeutics, up from -$15.1 million in the prior quarter.
- Across five years, Profit After Tax topped out at $56.5 million in Q1 2025 and bottomed at -$25.5 million in Q1 2022.
- A 5-year average of -$13.3 million and a median of -$18.2 million in 2024 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2025 — Profit After Tax soared 410.24% — and 2026, when it plunged 116.22%.
- Black Diamond Therapeutics' Profit After Tax stood at -$19.0 million in 2022, then advanced by 7.33% to -$17.6 million in 2023, then gained by 9.52% to -$15.9 million in 2024, then grew by 5.13% to -$15.1 million in 2025, then surged by 39.32% to -$9.2 million in 2026.
- Business Quant data shows BDTX's Profit After Tax at -$9.2 million in Q1 2026, -$15.1 million in Q4 2025, and -$8.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -453.82 Mn |
| 10 | Black Diamond Therapeutics | 99.59 Mn | -18.67 Mn | - | -9.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.17 Mn |
| Dec 31, 2025 | -15.12 Mn |
| Sep 30, 2025 | -8.33 Mn |
| Jun 30, 2025 | -10.56 Mn |
| Mar 31, 2025 | 56.54 Mn |
| Dec 31, 2024 | -15.93 Mn |
| Sep 30, 2024 | -15.56 Mn |
| Jun 30, 2024 | -19.91 Mn |
| Mar 31, 2024 | -18.23 Mn |
| Dec 31, 2023 | -17.61 Mn |
| Sep 30, 2023 | -23.01 Mn |
| Jun 30, 2023 | -19.15 Mn |
| Mar 31, 2023 | -20.88 Mn |
| Dec 31, 2022 | -19.00 Mn |
| Sep 30, 2022 | -21.65 Mn |
| Jun 30, 2022 | -22.93 Mn |
| Mar 31, 2022 | -25.51 Mn |
| Dec 31, 2021 | -25.87 Mn |
| Sep 30, 2021 | -35.15 Mn |
| Jun 30, 2021 | -34.35 Mn |